DA-002
- Generic Name
- DA-002
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Phase 3
Not yet recruiting
- Conditions
- Androgenetic AlopeciaFemale Pattern BaldnessMale Pattern Baldness
- Interventions
- Dietary Supplement: DA-005Other: Placebo Topical SolutionDietary Supplement: Placebo Oral Tablet
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 516
- Registration Number
- NCT06501924
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath